当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2018年第9期
编号:13233109
黄芪多糖抑制糖尿病心肌氧化应激的初步研究(4)
http://www.100md.com 2018年3月25日 《中国医药导报》 2018年第9期
     [11] Ascencio-Montiel Ide J,Parra EJ,Valladares-Salgado A,et al. SOD2 gene Val16Ala polymorphism is associated with macroalbuminuria in Mexican type 2 diabetes patients:a comparative study and meta-analysis [J]. BMC Med Genet,2013,14:110-121.

    [12] Du K,Yu Y,Zhang D,et al. NFκB1(p50)suppresses SOD2 expression by inhibiting FoxO3a transactivation in a miR190/PHLPP1/Akt-dependent axis [J]. Mol Biol Cell,2013,24(22):3577-3583.

    [13] Chen W,Li YM,Yu MH. Astragalus Polysaccharides:An Effective Treatment for Diabetes Prevention in NOD Mice [J]. Exp Clin Endocr Diab,2008,116(8):468-474.

    [14] Chen W,Li YM,Yu MH. Astragalus polysaccharides inhibited diabetic cardiomyopath in hamsters depending on supression of heart chymase activation [J]. J Diabetes Complicat,2010,24(3):199-208.

    [15] Chen W,Xia YP,Chen WJ,et al. Improvement of myocardial glycolipid metabolic disorder in diabetic hamster with Astragalus polysaccharides treatment [J]. Mol Biol Rep,2012,39(7):7609-7615.

    [16] Chen W,Chen WJ,Xia YP,et al. Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARa mice [J]. Mol Biol Rep,2013,40(3):2449-2459.

    (收稿日期:2017-09-04 本文編辑:张瑜杰), 百拇医药(陈蔚 鞠婧 王浩)
上一页1 2 3 4